Wave Life Sciences Ownership 2024 | Who Owns Wave Life Sciences Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

86.16%

Insider Ownership

18.18%

Retail Ownership

-4.34%

Institutional Holders

133.00

Wave Life Sciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RA CAPITAL MANAGEMENT, L.P.17.16%0.16%18,202,009--112,306,396Mar 31, 2024
MAVERICK CAPITAL LTD7.25%0.89%7,688,079-759,725-8.99%47,435,447Mar 31, 2024
M28 CAPITAL MANAGEMENT LP6.60%31.91%7,000,000-373,413-5.06%43,190,000Mar 31, 2024
BLACKROCK INC.6.01%0.00%6,375,2501,008,96218.80%39,335,294Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC5.04%2.42%5,350,000-250,000-4.46%33,009,500Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.4.90%0.06%5,201,389-786,341-13.13%32,092,570Mar 31, 2024
BELLEVUE GROUP AG3.86%0.39%4,094,458-400,000-8.90%25,262,806Mar 31, 2024
ARTAL GROUP S.A.3.82%0.64%4,051,4001,044,00034.71%24,997,138Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP3.71%2.54%3,932,082--24,260,946Mar 31, 2024
PRIMECAP MANAGEMENT CO/CA/2.71%0.01%2,876,440-882,968-23.49%17,747,635Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.1.86%0.03%1,974,737-1,238,763-38.55%12,184,127Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.80%0.00%1,912,742452,97831.03%11,802,961Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.75%0.00%1,861,254233,89114.37%11,485,000Mar 31, 2024
VANGUARD GROUP INC1.73%0.00%1,834,090521,66539.75%11,316,335Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.54%0.00%1,635,6101,121,029217.85%10,091,714Mar 31, 2024
STATE STREET CORP1.43%0.00%1,514,419250,69019.84%9,343,965Mar 31, 2024
FMR LLC1.10%0.00%1,168,773-33,442-2.78%7,211,329Mar 31, 2024
WOODLINE PARTNERS LP0.89%0.05%948,444-443,117-31.84%5,851,899Mar 31, 2024
MORGAN STANLEY0.89%0.00%945,120754,792396.57%5,831,390Mar 31, 2024
LAURION CAPITAL MANAGEMENT LP0.82%0.05%871,500-200,000-18.67%5,377,155Mar 31, 2024

Wave Life Sciences's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 17.16% of the company's total share outstanding, currently valued at $112.31M. The top 10 institutional shareholders own together 61.05% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
M28 CAPITAL MANAGEMENT LP6.60%31.91%7,000,000-373,413-5.06%43,190,000Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP3.71%2.54%3,932,082--24,260,946Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC5.04%2.42%5,350,000-250,000-4.46%33,009,500Mar 31, 2024
MAVERICK CAPITAL LTD7.25%0.89%7,688,079-759,725-8.99%47,435,447Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.47%0.85%495,471495,471100.00%3,057,056Mar 31, 2024
ARTAL GROUP S.A.3.82%0.64%4,051,4001,044,00034.71%24,997,138Mar 31, 2024
NEWTYN MANAGEMENT, LLC0.47%0.61%500,000-10,000-1.96%3,085,000Mar 31, 2024
IKARIAN CAPITAL, LLC0.56%0.40%590,088590,088100.00%3,640,843Mar 31, 2024
BELLEVUE GROUP AG3.86%0.39%4,094,458-400,000-8.90%25,262,806Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.27%0.22%286,585286,585100.00%1,768,229Mar 31, 2024
BIRCHVIEW CAPITAL, LP0.04%0.20%40,000--246,800Mar 31, 2024
RA CAPITAL MANAGEMENT, L.P.17.16%0.16%18,202,009--112,306,396Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD0.57%0.15%600,155-55,176-8.42%3,702,956Mar 31, 2024
KRAEMATON INVESTMENT ADVISORS, INC0.02%0.14%22,000-25,000-53.19%135,740Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.4.90%0.06%5,201,389-786,341-13.13%32,092,570Mar 31, 2024
WOODLINE PARTNERS LP0.89%0.05%948,444-443,117-31.84%5,851,899Mar 31, 2024
CORNERCAP INVESTMENT COUNSEL INC0.05%0.05%56,05156,051100.00%345,835Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.14%0.05%144,300144,300100.00%890,331Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.09%0.05%95,03795,037100.00%586,000Mar 31, 2024
LAURION CAPITAL MANAGEMENT LP0.82%0.05%871,500-200,000-18.67%5,377,155Mar 31, 2024

The largest Wave Life Sciences shareholder by % of total assets is M28 CAPITAL MANAGEMENT LP. The company owns 7.00M shares of Wave Life Sciences (WVE), representing 31.91% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC1.54%0.00%1,635,6101,121,029217.85%10,091,714Mar 31, 2024
ARTAL GROUP S.A.3.82%0.64%4,051,4001,044,00034.71%24,997,138Mar 31, 2024
BLACKROCK INC.6.01%0.00%6,375,2501,008,96218.80%39,335,294Mar 31, 2024
MORGAN STANLEY0.89%0.00%945,120754,792396.57%5,831,390Mar 31, 2024
IKARIAN CAPITAL, LLC0.56%0.40%590,088590,088100.00%3,640,843Mar 31, 2024
VANGUARD GROUP INC1.73%0.00%1,834,090521,66539.75%11,316,335Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.47%0.85%495,471495,471100.00%3,057,056Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.44%0.01%462,582462,582100.00%2,854,131Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.80%0.00%1,912,742452,97831.03%11,802,961Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.39%0.01%416,725390,1821470.00%2,571,193Mar 31, 2024
ALLIANCEBERNSTEIN L.P.0.32%0.00%336,589324,6892728.48%2,076,754Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.27%0.22%286,585286,585100.00%1,768,229Mar 31, 2024
D. E. SHAW & CO., INC.0.27%0.00%285,092285,092100.00%1,759,018Mar 31, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.41%0.00%433,577263,884155.51%2,675,170Mar 31, 2024
STATE STREET CORP1.43%0.00%1,514,419250,69019.84%9,343,965Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.75%0.00%1,861,254233,89114.37%11,485,000Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.16%0.02%171,926171,926100.00%1,060,783Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.16%0.00%164,620149,9201019.86%1,016,000Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.14%0.05%144,300144,300100.00%890,331Mar 31, 2024
NORTHERN TRUST CORP0.71%0.00%757,291130,84120.89%4,672,485Mar 31, 2024

As of Mar 31 2024, Wave Life Sciences's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 1.12M stocks of WVE, valued at $10.09M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CITADEL ADVISORS LLC0.08%0.00%84,629-1,897,623-95.73%522,161Mar 31, 2024
MAVEN SECURITIES LTD----1,452,778-100.00%-Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.1.86%0.03%1,974,737-1,238,763-38.55%12,184,127Mar 31, 2024
PRIMECAP MANAGEMENT CO/CA/2.71%0.01%2,876,440-882,968-23.49%17,747,635Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.4.90%0.06%5,201,389-786,341-13.13%32,092,570Mar 31, 2024
MAVERICK CAPITAL LTD7.25%0.89%7,688,079-759,725-8.99%47,435,447Mar 31, 2024
WOODLINE PARTNERS LP0.89%0.05%948,444-443,117-31.84%5,851,899Mar 31, 2024
BELLEVUE GROUP AG3.86%0.39%4,094,458-400,000-8.90%25,262,806Mar 31, 2024
WALLEYE CAPITAL LLC0.05%0.00%55,129-377,804-87.27%340,146Mar 31, 2024
M28 CAPITAL MANAGEMENT LP6.60%31.91%7,000,000-373,413-5.06%43,190,000Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC5.04%2.42%5,350,000-250,000-4.46%33,009,500Mar 31, 2024
LAURION CAPITAL MANAGEMENT LP0.82%0.05%871,500-200,000-18.67%5,377,155Mar 31, 2024
WS MANAGEMENT LLLP----192,722-100.00%-Mar 31, 2024
MARSHALL WACE, LLP0.30%0.00%313,405-186,804-37.35%1,933,708Mar 31, 2024
MONASHEE INVESTMENT MANAGEMENT LLC----103,300-100.00%-Mar 31, 2024
BARCLAYS PLC0.09%0.00%93,794-87,473-48.26%579,000Mar 31, 2024
JAMES J. BURNS & COMPANY, LLC----65,049-100.00%-Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.03%0.00%27,541-61,429-69.04%169,928Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD0.57%0.15%600,155-55,176-8.42%3,702,956Mar 31, 2024
GOLDMAN SACHS GROUP INC0.32%0.00%340,678-50,454-12.90%2,101,983Mar 31, 2024

As of Mar 31 2024, Wave Life Sciences's biggest institutional seller is CITADEL ADVISORS LLC. The company sold -1.90M shares of WVE, valued at $522.16K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IKARIAN CAPITAL, LLC0.56%0.40%590,088590,088100.00%3,640,843Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.47%0.85%495,471495,471100.00%3,057,056Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.44%0.01%462,582462,582100.00%2,854,131Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.27%0.22%286,585286,585100.00%1,768,229Mar 31, 2024
D. E. SHAW & CO., INC.0.27%0.00%285,092285,092100.00%1,759,018Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.16%0.02%171,926171,926100.00%1,060,783Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.14%0.05%144,300144,300100.00%890,331Mar 31, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.11%0.00%113,840113,840100.00%702,000Mar 31, 2024
FRANKLIN RESOURCES INC0.09%0.00%97,14297,142100.00%599,366Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.09%0.05%95,03795,037100.00%586,000Mar 31, 2024
TWO SIGMA ADVISERS, LP0.08%0.00%86,10086,100100.00%531,237Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.06%0.02%65,56565,565100.00%404,536Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.05%0.00%58,10058,100100.00%358,477Mar 31, 2024
CORNERCAP INVESTMENT COUNSEL INC0.05%0.05%56,05156,051100.00%345,835Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.04%0.00%42,22342,223100.00%260,516Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.03%0.04%30,00030,000100.00%185,100Mar 31, 2024
ATOM INVESTORS LP0.02%0.02%20,64020,640100.00%127,349Mar 31, 2024
MACKENZIE FINANCIAL CORP0.01%0.00%13,98213,982100.00%86,269Mar 31, 2024
PDT PARTNERS, LLC0.01%0.01%13,30013,300100.00%82,061Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.01%-12,80012,800100.00%78,976Mar 31, 2024
VICTORY CAPITAL MANAGEMENT INC0.01%0.00%11,58211,582100.00%71,461Mar 31, 2024
0.01%0.00%8,9718,971100.00%55,349Mar 31, 2024
QUADRANT CAPITAL GROUP LLC0.00%0.00%2,3962,396100.00%14,784Mar 31, 2024
HILLSDALE INVESTMENT MANAGEMENT INC.0.00%0.00%1,1001,100100.00%6,787Mar 31, 2024
RUSSELL INVESTMENTS GROUP, LTD.0.00%-1,0071,007100.00%6,212Mar 31, 2024
NATIONAL BANK OF CANADA /FI/0.00%-100100100.00%562Mar 31, 2024
GAMMA INVESTING LLC0.00%0.00%6262100.00%383Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--1212100.00%74Mar 31, 2024

Wave Life Sciences's largest new institutional shareholder by number of shares is IKARIAN CAPITAL, LLC, purchased 590.09K shares, valued at $3.64M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MAVEN SECURITIES LTD----1,452,778-100.00%-Mar 31, 2024
WS MANAGEMENT LLLP----192,722-100.00%-Mar 31, 2024
MONASHEE INVESTMENT MANAGEMENT LLC----103,300-100.00%-Mar 31, 2024
JAMES J. BURNS & COMPANY, LLC----65,049-100.00%-Mar 31, 2024
TUDOR INVESTMENT CORP ET AL----36,580-100.00%-Mar 31, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.----35,523-100.00%-Mar 31, 2024
SG AMERICAS SECURITIES, LLC----34,562-100.00%-Mar 31, 2024
SEI INVESTMENTS CO----29,000-100.00%-Mar 31, 2024
FOX RUN MANAGEMENT, L.L.C.----20,053-100.00%-Mar 31, 2024
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM----16,950-100.00%-Mar 31, 2024
HRT FINANCIAL LP----14,681-100.00%-Mar 31, 2024
OXFORD ASSET MANAGEMENT LLP----10,045-100.00%-Mar 31, 2024
STATE OF WYOMING----7,244-100.00%-Mar 31, 2024
FORTITUDE FAMILY OFFICE, LLC----64-100.00%-Mar 31, 2024

Wave Life Sciences's largest sold out institutional shareholder by shares sold is MAVEN SECURITIES LTD, sold -1.45M shares, valued at -, as of undefined.

Wave Life Sciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
PRIMECAP Odyssey Funds0.46%3,768,470--Jan 31, 2024
Clough Funds Trust0.22%9,200--Jan 31, 2023
TIAA SEPARATE ACCOUNT VA 10.01%1,512-5,067-77.02%Dec 31, 2023
VANGUARD INDEX FUNDS0.00%1,945,3861,034,753113.63%Dec 31, 2023
VANGUARD HORIZON FUNDS0.00%48,932--Dec 31, 2023
ALGER FUNDS0.00%2,000--Jan 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%13,200--Dec 31, 2023
OHIO NATIONAL FUND INC0.00%25,105--Dec 31, 2023
VANGUARD VARIABLE INSURANCE FUNDS0.00%45,825--Dec 31, 2023
Forethought Variable Insurance Trust0.00%3,600--Dec 29, 2023
Meeder Funds0.00%3,975--Mar 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%971-19,726-95.31%Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%909--Dec 31, 2023
JOHN HANCOCK INVESTMENT TRUST0.00%11,271--Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%259,23627,90912.06%Feb 29, 2024
ProFunds0.00%84234569.42%Jan 31, 2024
HC CAPITAL TRUST0.00%1,883--Dec 31, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%2,587--Dec 31, 2023
NORTHERN FUNDS0.00%33,770--Dec 29, 2023
Invesco Exchange-Traded Fund Trust II0.00%9,353-80-0.85%Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%29,537--Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%51,54811,15627.62%Dec 31, 2023
VANGUARD WELLINGTON FUND0.00%8,294--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,969--Feb 29, 2024
Brinker Capital Destinations Trust0.00%1,097--Feb 29, 2024
AMERICAN CENTURY ETF TRUST0.00%1,879--Feb 29, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%31,495--Dec 31, 2023
COLUMBIA FUNDS SERIES TRUST I0.00%25,99425,994-Feb 29, 2024
Bridge Builder Trust0.00%25,203--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%3,328--Dec 31, 2023
John Hancock Funds II0.00%42,61124,611136.73%Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC0.00%860--Dec 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%20,850-410-1.93%Feb 29, 2024
VANGUARD WORLD FUND0.00%68--Feb 29, 2024
Dimensional ETF Trust0.00%94--Jan 31, 2024

Wave Life Sciences's largest mutual fund holder by % of total assets is "PRIMECAP Odyssey Funds", owning 3.77M shares, compromising 0.46% of its total assets.

Wave Life Sciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2413315.65%
31 Dec, 2311535.29%
30 Sep, 23853.66%
30 Jun, 238210.81%
31 Mar, 2374-2.63%
31 Dec, 227628.81%
30 Sep, 22591.72%
30 Jun, 2258-26.58%
31 Mar, 2279-16.84%
31 Dec, 21959.20%
30 Sep, 2187-
30 Jun, 2187-22.32%
31 Mar, 21112-
31 Dec, 20112-
30 Sep, 2011220.43%
30 Jun, 209312.05%
31 Mar, 2083-23.85%
31 Dec, 1910919.78%
30 Sep, 1991-15.74%
30 Jun, 19108-5.26%
31 Mar, 1911423.91%
31 Dec, 1892-
30 Sep, 189217.95%
30 Jun, 1878-1.27%
31 Mar, 18799.72%
31 Dec, 177224.14%
30 Sep, 17583.57%
30 Jun, 175612.00%
31 Mar, 1750-1.96%
31 Dec, 165110.87%
30 Sep, 164621.05%
30 Jun, 163880.95%
31 Mar, 162110.53%
31 Dec, 1519-

As of 31 Mar 24, 133 institutions are holding Wave Life Sciences's shares, representing an increase of 15.65% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2491,412,7020.28%
31 Dec, 2391,159,81225.57%
30 Sep, 2372,599,4000.63%
30 Jun, 2372,146,3824.02%
31 Mar, 2369,357,463-95.72%
31 Dec, 221,621,127,2232311.60%
30 Sep, 2267,222,112-0.83%
30 Jun, 2267,785,42742.13%
31 Mar, 2247,692,4790.80%
31 Dec, 2147,313,30326.44%
30 Sep, 2137,418,8061.18%
30 Jun, 2136,981,086-3.21%
31 Mar, 2138,208,5415.88%
31 Dec, 2036,086,986-2.32%
30 Sep, 2036,945,35526.38%
30 Jun, 2029,233,533-2.65%
31 Mar, 2030,029,3922.03%
31 Dec, 1929,432,050-4.62%
30 Sep, 1930,856,8701.35%
30 Jun, 1930,447,1533.56%
31 Mar, 1929,400,29320.53%
31 Dec, 1824,393,0642.48%
30 Sep, 1823,803,154-2.71%
30 Jun, 1824,465,3893.39%
31 Mar, 1823,663,8236.47%
31 Dec, 1722,225,3578.46%
30 Sep, 1720,492,6026.09%
30 Jun, 1719,316,34322.72%
31 Mar, 1715,739,7016.19%
31 Dec, 1614,822,2735.41%
30 Sep, 1614,061,154-0.98%
30 Jun, 1614,199,6371.50%
31 Mar, 1613,989,8021.46%
31 Dec, 1513,788,882-

Wave Life Sciences (WVE) has 91.41M shares outstanding as of 31 Mar 24, up 0.28% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2486.16%1.17%
31 Dec, 2385.98%1.81%
30 Sep, 2368.84%1.38%
30 Jun, 2370.69%1.53%
31 Mar, 2367.96%0.00%
31 Dec, 221724.72%33.65%
30 Sep, 2271.59%0.69%
30 Jun, 22101.96%1.64%
31 Mar, 2278.81%0.95%
31 Dec, 2191.29%1.68%
30 Sep, 2173.79%1.35%
30 Jun, 2174.00%1.22%
31 Mar, 2177.82%1.42%
31 Dec, 2073.98%0.80%
30 Sep, 2096.30%1.40%
30 Jun, 2083.02%1.09%
31 Mar, 2087.14%1.18%
31 Dec, 1985.80%1.06%
30 Sep, 1990.01%1.14%
30 Jun, 1988.87%1.09%
31 Mar, 1990.19%1.27%
31 Dec, 1884.20%1.28%
30 Sep, 1881.15%1.15%
30 Jun, 1883.95%1.17%
31 Mar, 1884.76%1.21%
31 Dec, 1783.83%1.54%
30 Sep, 1773.82%1.43%
30 Jun, 1771.81%1.61%
31 Mar, 1766.89%1.69%
31 Dec, 1662.99%1.75%
30 Sep, 1659.97%1.53%
30 Jun, 1662.53%1.48%
31 Mar, 1664.91%1.59%
31 Dec, 1563.98%-

As of 31 Mar 24, Wave Life Sciences is held by 86.16% institutional shareholders, representing a 1.17% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 24871.16%
31 Dec, 2386126.32%
30 Sep, 2338-19.15%
30 Jun, 234723.68%
31 Mar, 2338-25.49%
31 Dec, 225182.14%
30 Sep, 222821.74%
30 Jun, 2223-17.86%
31 Mar, 2228-50.88%
31 Dec, 215742.50%
30 Sep, 2140-9.09%
30 Jun, 2144-6.38%
31 Mar, 2147-18.97%
31 Dec, 2058-18.31%
30 Sep, 207142.00%
30 Jun, 205016.28%
31 Mar, 2043-23.21%
31 Dec, 195633.33%
30 Sep, 1942-39.13%
30 Jun, 1969-20.69%
31 Mar, 198781.25%
31 Dec, 1848-
30 Sep, 1848-5.88%
30 Jun, 18516.25%
31 Mar, 184823.08%
31 Dec, 173921.88%
30 Sep, 1732-23.81%
30 Jun, 174255.56%
31 Mar, 1727-12.90%
31 Dec, 163114.81%
30 Sep, 1627-6.90%
30 Jun, 1629190.00%
31 Mar, 1610-47.37%
31 Dec, 1519-

87 institutional shareholders have increased their position in WVE stock as of 31 Mar 24 compared to 86 in the previous quarter (a 1.16% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2432220.00%
31 Dec, 2310-64.29%
30 Sep, 232855.56%
30 Jun, 2318-30.77%
31 Mar, 232662.50%
31 Dec, 2216-5.88%
30 Sep, 2217-37.04%
30 Jun, 2227-18.18%
31 Mar, 223373.68%
31 Dec, 2119-26.92%
30 Sep, 2126-3.70%
30 Jun, 2127-20.59%
31 Mar, 213413.33%
31 Dec, 20303.45%
30 Sep, 202911.54%
30 Jun, 202613.04%
31 Mar, 2023-25.81%
31 Dec, 1931-
30 Sep, 193163.16%
30 Jun, 191926.67%
31 Mar, 1915-54.55%
31 Dec, 183322.22%
30 Sep, 182735.00%
30 Jun, 1820-4.76%
31 Mar, 1821-16.00%
31 Dec, 1725108.33%
30 Sep, 171250.00%
30 Jun, 178-38.46%
31 Mar, 171318.18%
31 Dec, 161110.00%
30 Sep, 1610100.00%
30 Jun, 165-
31 Mar, 165-
31 Dec, 15--

32 institutional shareholders have reduced their position in WVE stock as of 31 Mar 24 compared to 10 in the previous quarter (a 220.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2413315.65%91,412,7020.28%86.16%1.17%871.16%32220.00%
31 Dec, 2311535.29%91,159,81225.57%85.98%1.81%86126.32%10-64.29%
30 Sep, 23853.66%72,599,4000.63%68.84%1.38%38-19.15%2855.56%
30 Jun, 238210.81%72,146,3824.02%70.69%1.53%4723.68%18-30.77%
31 Mar, 2374-2.63%69,357,463-95.72%67.96%0.00%38-25.49%2662.50%
31 Dec, 227628.81%1,621,127,2232311.60%1724.72%33.65%5182.14%16-5.88%
30 Sep, 22591.72%67,222,112-0.83%71.59%0.69%2821.74%17-37.04%
30 Jun, 2258-26.58%67,785,42742.13%101.96%1.64%23-17.86%27-18.18%
31 Mar, 2279-16.84%47,692,4790.80%78.81%0.95%28-50.88%3373.68%
31 Dec, 21959.20%47,313,30326.44%91.29%1.68%5742.50%19-26.92%
30 Sep, 2187-37,418,8061.18%73.79%1.35%40-9.09%26-3.70%
30 Jun, 2187-22.32%36,981,086-3.21%74.00%1.22%44-6.38%27-20.59%
31 Mar, 21112-38,208,5415.88%77.82%1.42%47-18.97%3413.33%
31 Dec, 20112-36,086,986-2.32%73.98%0.80%58-18.31%303.45%
30 Sep, 2011220.43%36,945,35526.38%96.30%1.40%7142.00%2911.54%
30 Jun, 209312.05%29,233,533-2.65%83.02%1.09%5016.28%2613.04%
31 Mar, 2083-23.85%30,029,3922.03%87.14%1.18%43-23.21%23-25.81%
31 Dec, 1910919.78%29,432,050-4.62%85.80%1.06%5633.33%31-
30 Sep, 1991-15.74%30,856,8701.35%90.01%1.14%42-39.13%3163.16%
30 Jun, 19108-5.26%30,447,1533.56%88.87%1.09%69-20.69%1926.67%
31 Mar, 1911423.91%29,400,29320.53%90.19%1.27%8781.25%15-54.55%
31 Dec, 1892-24,393,0642.48%84.20%1.28%48-3322.22%
30 Sep, 189217.95%23,803,154-2.71%81.15%1.15%48-5.88%2735.00%
30 Jun, 1878-1.27%24,465,3893.39%83.95%1.17%516.25%20-4.76%
31 Mar, 18799.72%23,663,8236.47%84.76%1.21%4823.08%21-16.00%
31 Dec, 177224.14%22,225,3578.46%83.83%1.54%3921.88%25108.33%
30 Sep, 17583.57%20,492,6026.09%73.82%1.43%32-23.81%1250.00%
30 Jun, 175612.00%19,316,34322.72%71.81%1.61%4255.56%8-38.46%
31 Mar, 1750-1.96%15,739,7016.19%66.89%1.69%27-12.90%1318.18%
31 Dec, 165110.87%14,822,2735.41%62.99%1.75%3114.81%1110.00%
30 Sep, 164621.05%14,061,154-0.98%59.97%1.53%27-6.90%10100.00%
30 Jun, 163880.95%14,199,6371.50%62.53%1.48%29190.00%5-
31 Mar, 162110.53%13,989,8021.46%64.91%1.59%10-47.37%5-
31 Dec, 1519-13,788,882-63.98%-19---

Wave Life Sciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 05, 2024Moran Kyleofficer Chief Financial OfficerS-SaleSell15,630$6.17$96.42K33,921
Jan 30, 2024GSK plc10 percent owner-P-PurchaseBuy3,300,000$5.00$16.50M13,983,761
Jan 17, 2024RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner P-PurchaseBuy1,000,000$5.00$5.00M18,202,009
Dec 13, 2023RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner P-PurchaseBuy1,000,000$5.00$5.00M19,202,009
Aug 23, 2023Moran Kyleofficer Chief Financial OfficerS-SaleSell37,062$4.75$176.12K46,120
Feb 17, 2023Vargeese Chandraofficer See RemarksS-SaleSell10,249$4.03$41.30K106,624

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 30, 2024GSK plc10 percent owner-P-PurchaseBuy3,300,000$5.00$16.50M13,983,761
Jan 17, 2024RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner P-PurchaseBuy1,000,000$5.00$5.00M18,202,009
Dec 13, 2023RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner P-PurchaseBuy1,000,000$5.00$5.00M19,202,009

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 05, 2024Moran Kyleofficer Chief Financial OfficerS-SaleSell15,630$6.17$96.42K33,921
Aug 23, 2023Moran Kyleofficer Chief Financial OfficerS-SaleSell37,062$4.75$176.12K46,120
Feb 17, 2023Vargeese Chandraofficer See RemarksS-SaleSell10,249$4.03$41.30K106,624

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 05, 2024Moran Kyleofficer Chief Financial OfficerS-SaleSell15,630$6.17$96.42K33,921
Feb 07, 2024Francis Chrisofficer See RemarksA-AwardBuy286,400$3.87$1.11M286,400
Feb 07, 2024BOLNO PAULdirector, officer President and CEOA-AwardBuy1,008,600$3.87$3.90M1,008,600
Feb 07, 2024Moran Kyleofficer Chief Financial OfficerA-AwardBuy371,500$3.87$1.44M371,500
Feb 07, 2024Vargeese Chandraofficer See RemarksA-AwardBuy361,700$3.87$1.40M361,700
Jan 30, 2024GSK plc10 percent owner-P-PurchaseBuy3,300,000$5.00$16.50M13,983,761
Jan 17, 2024RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner P-PurchaseBuy1,000,000$5.00$5.00M18,202,009
Dec 13, 2023RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner P-PurchaseBuy1,000,000$5.00$5.00M19,202,009
Aug 23, 2023Moran Kyleofficer Chief Financial OfficerS-SaleSell37,062$4.75$176.12K46,120
Aug 09, 2023Tan Aik Nadirector-A-AwardBuy45,000$4.58$206.10K45,000
Aug 09, 2023RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner A-AwardBuy45,000$4.58$206.10K45,000
Aug 09, 2023TAKANASHI KENdirector, 10 percent owner A-AwardBuy45,000$4.58$206.10K45,000
Aug 09, 2023Wagner Heidi Ldirector-A-AwardBuy45,000$4.58$206.10K45,000
Aug 09, 2023CORRIGAN MARKdirector-A-AwardBuy45,000$4.58$206.10K45,000
Aug 09, 2023Rawcliffe Adriandirector-A-AwardBuy45,000$4.58$206.10K45,000
Aug 09, 2023Verdine Gregory L.director-A-AwardBuy45,000$4.58$206.10K45,000
Aug 09, 2023HENRY CHRISTIAN Odirector-A-AwardBuy45,000$4.58$206.10K45,000
Feb 17, 2023Vargeese Chandraofficer See RemarksA-AwardBuy295,400$4.75$1.40M295,400
Feb 17, 2023Vargeese Chandraofficer See RemarksS-SaleSell10,249$4.03$41.30K106,624
Feb 17, 2023BOLNO PAULdirector, officer President and CEOA-AwardBuy771,000$4.75$3.66M771,000

The last insider sell of Wave Life Sciences's stock was made by Moran Kyle on Apr 05 2024, selling 15,630 shares at $6.17 per share (valued at $96.42K). The last insider buy of WVE was made by GSK plc on Jan 30 2024, buying 3,300,000 shares at $5.00 per share (worth $16.50M).

Wave Life Sciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-1-
Q1 20244--
Q4 20233--
Q3 202381800.00%
Q1 202344100.00%
Q4 20221--
Q3 202223--
Q2 202285160.00%
Q1 202255100.00%
Q3 20218--
Q2 20212--
Q1 2021116183.33%
Q4 2020-5-
Q3 2020129133.33%
Q1 20205771.43%
Q4 20191520.00%
Q3 2019122600.00%
Q1 201971258.33%
Q4 2018-2-
Q3 20181210120.00%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Wave Life Sciences's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-1-
Q1 2024---
Q4 20233--
Q3 2023-1-
Q1 2023-4-
Q4 2022---
Q3 2022---
Q2 20223560.00%
Q1 2022-5-
Q3 2021---
Q2 2021---
Q1 2021-5-
Q4 2020---
Q3 2020-6-
Q1 2020-5-
Q4 2019-4-
Q3 2019-2-
Q1 20191119.09%
Q4 2018-2-
Q3 2018-5-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Wave Life Sciences's stocks.

Wave Life Sciences Peer Ownership


TickerCompany
TERNTerns Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
MREOMereo BioPharma Group plc
TCRXTScan Therapeutics, Inc.
VECTVectivBio Holding AG
XFORX4 Pharmaceuticals, Inc.
ITOSiTeos Therapeutics, Inc.
ALNYAlnylam Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
PRQRProQR Therapeutics N.V.
DAWNDay One Biopharmaceuticals, Inc.
ARWRArrowhead Pharmaceuticals, Inc.
AMLXAmylyx Pharmaceuticals, Inc.
BPMCBlueprint Medicines Corporation
CTMXCytomX Therapeutics, Inc.
APLSApellis Pharmaceuticals, Inc.
NLTXNeurogene Inc.
ASMBAssembly Biosciences, Inc.

WVE Ownership FAQ


Wave Life Sciences is owned by institutional shareholders (86.16%), insiders (18.18%), and public (-4.34%). The largest institutional shareholder of Wave Life Sciences is RA CAPITAL MANAGEMENT, L.P. (17.16% of total shares) and the top mutual fund owner is PRIMECAP Odyssey Funds (0.46% of total shares).

Wave Life Sciences's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., MAVERICK CAPITAL LTD, M28 CAPITAL MANAGEMENT LP, BLACKROCK INC., and 683 CAPITAL MANAGEMENT, LLC. The top five shareholders own together 42.05% of the company's share outstanding.

As of Mar 2024, there are 133 institutional shareholders of Wave Life Sciences.

RA CAPITAL MANAGEMENT, L.P owns 18.2M shares of Wave Life Sciences, representing 17.16% of the company's total shares outstanding, valued at $112.31M (as of Mar 2024).

As of Mar 2024, MAVERICK CAPITAL LTD holds 7.69M shares of Wave Life Sciences (WVE), compromising 7.25% of the company, valued at $47.44M.

M28 CAPITAL MANAGEMENT LP is the third largest holder of Wave Life Sciences. The company owns 7M of the company's shares outstanding (worth $43.19M).